2025-11-14T15:32:50-06:00 2024-12-31 911194016 CLARK NUBER PS 555 110TH AVE NE SUITE 700 BELLEVUE WA 98004 990 2024-01-01 264489946 SAGE BIONETWORKS SAGE 2069288250 2901 THIRD AVE 330 SEATTLE WA 98121 LUCA FOSCHINI PRESIDENT & CEO 2069288250 2025-11-13 1 0 MEGAN R RYAN P00737884 4254544919 2025-11-13 2024 2025-03-06 01:10:19Z LUCA FOSCHINI 2901 THIRD AVE 330 SEATTLE WA 98121 24609384 0 X WWW.SAGEBIONETWORKS.ORG X 2009 WA DRIVE A NEW AGE OF DISCOVERY IN MEDICINE THROUGH TRULY OPEN SCIENCE AND RADICAL COLLABORATION. 8 7 133 7 0 0 20131088 18637656 6198781 5879606 0 -59998 0 92120 26329869 24549384 2177616 2079513 0 0 19247056 18208209 30434 948 112987 4952847 4416997 26407953 24705667 -78084 -156283 10800289 8199571 7213444 4769009 3586845 3430562 SAGE BIONETWORKS IS ON A MISSION TO DRIVE A NEW AGE OF DISCOVERY THROUGH TRULY OPEN SCIENCE AND RADICAL COLLABORATION. WE AIM TO CREATE A WORLD WHERE SILOS WITHIN AND ACROSS SCIENCE AND TECHNOLOGY NO LONGER EXIST, FORGING A PATH TO OPTIMAL HUMAN HEALTH. 0 0 16434759 1724018 3941385 DATA COORDINATION & SHARING - IN 2024 SAGE BIONETWORKS EXPANDED ACCESS TO BIOMEDICAL DATA, INCREASING AVERAGE MONTHLY SYNAPSE USERS BY 20% AND HAD OVER 33,000 UNIQUE USERS DOWNLOADING DATA (+32%). KEY HIGHLIGHTS INCLUDED THE LAUNCH OF THE AACR PROJECT GENIE PORTAL, WHICH CENTRALIZES CANCER DATASETS FROM 19 CENTERS AND NEARLY 200,000 SEQUENCED SAMPLES ACROSS 111 CANCER TYPES WITH REAL-TIME RELEASE UPDATES. THE AMP-ALS INITIATIVE SELECTED SAGE TO BUILD AN ALS KNOWLEDGE PORTAL MODELED ON THE ALZHEIMER'S PORTAL. SAGE ALSO ENTERED INTO A PARTNERSHIP WITH THE ALZHEIMER'S DISEASE DATA INITIATIVE TO LINK THE AD WORKBENCH WITH THE AD KNOWLEDGE PORTAL, CREATING A UNIFIED ECOSYSTEM TO ACCELERATE EFFECTIVE TREATMENTS AND CURES FOR ALZHEIMER'S DISEASE. 6187634 355494 1938221 TOOLS & METHODS - SAGE ADVANCED ITS TOOLING TO MAKE DATA MORE USABLE AND INTEROPERABLE. INTEGRATION OF CAVATICA INTO THE ALZHEIMER'S DISEASE KNOWLEDGE PORTAL ENABLED DIRECT EXPORT TO A CLOUD-BASED ANALYSIS ENVIRONMENT. SYNAPSE INTRODUCED SYNAPSECHAT, AN AI-ASSISTED CONVERSATIONAL SEARCH TOOL AND NEW HOSTING OPTIONS THROUGH AWS OPEN DATA. PARTICIPATION IN THE VERILY-LED SYSBIO FAIRPLEX PROJECT ADVANCED A MULTI-MODAL AMP DATA PLATFORM, WHILE AN ARPA-H AWARD SUPPORTED DEVELOPMENT OF THE BIOMEDICAL DATA FABRIC TOOLBOX FOR EFFICIENT, EVIDENCE-BASED ANALYSIS OF LARGE BIOMEDICAL DATASETS. 22622393 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 0 1 0 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 39 0 133 1 0 0 0 0 0 0 0 0 0 0 0 0 X 8 7 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 WA X X BRANDON MORGAN 2069288243 2901 THIRD AVE STE 330 SEATTLE WA 98121 LUCA FOSCHINI PRESIDENT & CEO 50.00 X X 365453 0 58421 STEPHEN FRIEND BOARD CHAIR 0.50 X X 0 0 0 TONY FORD-HUTCHINSON TREASURER 0.50 X X 0 0 0 ERIC SCHADT DIRECTOR 0.50 X 0 0 0 GUSTAVO STOLOVITSKY DIRECTOR 0.50 X 0 0 0 CAROLE GOBLE DIRECTOR 0.50 X 0 0 0 JENNIFER GOLDSACK DIRECTOR 0.50 X 0 0 0 BRIAN FOX DIRECTOR 0.50 X 0 0 0 KIMBERLY BAGGETT COO, CFO AND SECRETARY 50.00 X 315997 0 53591 SUSHEEL VARMA CHIEF SCIENTIFIC & DATA OFFICER 50.00 X 218071 0 13819 CHRISTINE FABRE SUVER CHIEF PRIVACY & COMPLIANCE OFFICER 50.00 X 193002 0 43811 ANNA GREENWOOD DIRECTOR ADTR (THRU 10/24) 50.00 X 159015 0 18942 BRUCE HOFF TECHNICAL DIRECTOR IT 50.00 X 196217 0 45176 JAY HODGSON TECHNICAL DIRECTOR WEB ENGINEERING 50.00 X 189428 0 33160 SOLVEIG SIEBERTS DIRECTOR DIGITAL HEALTH 50.00 X 184983 0 23614 KEVIN BOSKE ASSOCIATE TECHNICAL DIRECTOR 50.00 X 181458 0 42257 MARCO MARASCA PRINCIPAL SOFTWARE ENGINEER 50.00 X 180493 0 12557 2184117 0 345348 63 0 1 0 GLOBALIZATION PARTNERS 175 FEDERAL STREET 17TH FLOOR BOSTON MA 02110 EMPLOYER OF RECORD FOR INTL EMPLOYEE 723215 AMAZON WEB SERVICES 410 TERRY AVENUE NORTH SEATTLE WA 98109 SCIENTIFIC COMPUTING 580772 FOUR POINTS TECHNOLOGY 13221 WOODLAND PARK ROAD SUITE 400 HERNDON VA 20171 SCIENTIFIC COMPUTING (AWS RESELLER) 342226 GOOGLE INC 600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 SCIENTIFIC COMP, STOR, & IT SERV 154227 RYAN SWANSON PLLC 401 UNION STREET SUITE 1500 SEATTLE WA 98101 LEGAL SERVICES 127190 5 9724004 8913652 18637656 SCIENTIFIC RES & DEV 541700 5879606 5879606 5879606 2 2 60000 -60000 -60000 -60000 GAIN ON LEASE GIVEBACK 900099 92120 92120 92120 24549384 5879606 0 32122 2079513 2079513 1440124 884894 517073 38157 13026054 11964974 1006956 54124 792476 729317 59459 3700 1875457 1801374 73048 1035 1074098 959529 108192 6377 212581 190724 21101 756 324052 291887 32165 1575 1575 948 948 529124 512554 15966 604 200204 185225 14407 572 1813822 1800624 12909 289 786030 703410 78021 4599 358285 339451 17786 1048 104564 99702 4591 271 1225 1096 122 7 15783 14124 1567 92 69752 62420 6924 408 24705667 22622393 1970287 112987 1982938 993225 10205 4114951 4344763 298535 328411 152111 132362 35532 19749 4368333 2503218 10800289 8199571 1068644 772137 1488265 1288718 4656535 2708154 7213444 4769009 X 3584900 3430562 1945 0 3586845 3430562 10800289 8199571 -156283 0 X 0 1 X 1 1 1 X 15521559 17940132 19068754 17594452 18637656 88762553 15521559 17940132 19068754 17594452 18637656 88762553 513650 88248903 414 79 120 2 615 3000 3000 92120 92120 88858288 29191358 0.99310 0.76000 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: GAIN ON LEASE GIVEBACK - 2024 AMOUNT: $ 92,120. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 1 1575 1575 0 PART II-B, LINE 1: WE ARE MEMBERS OF AIRI AND LIFE SCIENCES WA, BOTH ENGAGE IN DIRECT LOBBYING WITH A SMALL PERCENTAGE OF OUR MEMBERSHIP FEES. 152111 132362 19749 19749 RIGHT-OF-USE ASSET 2503218 2503218 LEASE LIABILITY 2708154 2708154 24949913 400529 400529 24549384 0 24549384 25106196 400529 400529 24705667 0 24705667 EUROPE (INCLUDING ICELAND & GREENLAND) 0 2 PROGRAM SERVICES PLATFORM DEVELOPMENT FOR SECURE DATA SHARING AND COLLABORATION; PROMOTION OF OPEN SCIENCE PRINCIPLES; ORGANIZE COMMUNITY CHALLENGES; AND ESTABLISH STANDARDS AND INCENTIVES FOR COLLABORATIVE RESEARCH. 393489 NORTH AMERICA 0 1 PROGRAM SERVICES PLATFORM DEVELOPMENT FOR SECURE DATA SHARING AND COLLABORATION; PROMOTION OF OPEN SCIENCE PRINCIPLES; ORGANIZE COMMUNITY CHALLENGES; AND ESTABLISH STANDARDS AND INCENTIVES FOR COLLABORATIVE RESEARCH. 40914 NORTH AMERICA 0 1 MANAGEMENT AND GENERAL EXPENSES N/A 96371 0 4 0 0 0 4 530774 0 530774 0 0 0 0 0 0 PART I, LINE 3: THE ACCRUAL METHOD IS USED TO ACCOUNT FOR EXPENDITURES. 1 SEVEN BRIDGES GENOMICS INC (VELSERA) 529 MAIN STREET SUITE 6610 CHARLESTOWN MA 02129 453415885 OTHER 412225 0 EXCEPTIONAL LONGEVITY DATA MANAGEMENT AND COORDINATING CENTER, DEVELOP INTEGRATION BETWEEN SAGE'S DATA SHARING PORTAL, SYNAPSE, AND CABATICA. PENNSYLVANIA STATE UNIVERSITY 110 TECHNOLOGY CENTER BUILDING UNIVERSITY PARK PA 16802 246000376 501(C)(3) 251814 0 PHASE 1 AND 2: RECOVER MOBILE HEALTH PLATFORM/MOBILE HEALTH REPOSITORIES WORKING GROUP: DEVELOP PROCESS FOR MHP TO COLLECT PASC RELATED MOBILE HEALTH DATA FROM PARTICIPANTS AND SHARE THIS DATA WITH MHDR TO CLEAN CURATE, CONDUCT QA/QC, STORE AND PROVIDE ACCESS TO RESEARCHERS. CUSTOMIZATION OF THE MOBILE HEALTH PLATFORM, IMPLEMENTATION OF MOBILE DATA COLLECTION AMONG THE VARIOUS STUDIES, AS WELL AS, THE STORING, CURATION, LINKAGE, AND ANALYSES OF THE MOBILE HEALTH DATA. INSTITUTE FOR SYSTEMS BIOLOGY 401 TERRY AVE N SEATTLE WA 98109 912003593 501(C)(3) 204222 0 CRI IMMUNE ATLAS 4 AND 5: PLATFORM FOR IMMUNE-ONCOLOGY RESEARCH AND DATA SHARING. EXCEPTIONAL LONGEVITY DATA MANAGEMENT AND COORDINATING CENTER, DESIGN AND PERFORM CROSS-PROJECT ANALYSIS FOCUSED ON HARNESSING SYSTEMS BIOLOGY-BASED TECHNIQUES, SUCH AS MULTI-OMIC DATA INTEGRATION, NETWORK ANALYSIS, MACHINE LEARNING, AND STATISTICAL MODELING, TO INVESTIGATE BOTH AGING AND DISEASE, AS WELL AS THE INTERPLAY BETWEEN THEM. UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 910 RALEIGH RD 3916 CHAPEL HILL NC 27514 566001393 501(C)(3) 169611 0 CRI IMMUNE ATLAS 4 AND 5: PLATFORM FOR IMMUNE-ONCOLOGY RESEARCH AND DATA SHARING. DEFINING REGRESSION MODELS AND VALIDATION METHODS FOR USE IN IMPLEMENTING STATISTICAL LEARNING MODELS FOR BIOMARKER DEVELOPMENT IN IATLAS. ADD COMPREHENSIVE TUMOR ANTIGEN PREDICTION FROM MULTIPLE GENOMIC SOURCES TO IATLAS DATASETS. HARMONIZE AND CURATE DATA FROM ADDITIONAL IO CLINICAL TRIALS WITH GENOMIC DATA FOR ANALYSIS USING THE IO RESPONSE MODULE. HARVARD OFFICE OF SPONSORED PROGRAMS 1635 TREMONT ST BOSTON MA 02120 042103580 501(C)(3) 156432 0 MULTI-CONSORTIA COORDINATING CENTER (MC2 CENTER) FOR CANCER BIOLOGY: BUILDING INTERDISCIPLINARY SCIENTIFIC COMMUNITIES, COORDINATING IMPACTFUL RESOURCE SHARING, AND ADVANCING CANCER RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 10065 131924236 501(C)(3) 136319 0 PERFORM ALL WORK RELATED TO THE PROPOSED BRCA PRE-CANCER ATLAS INSTANCE OF THE CBIOPORTAL FOR CANCER GENOMICS. BUILD, MAINTAIN AND RUN AUTOMATED PIPELINES THAT TRANSFER DATA FROM SYNAPSE INTO BRCA PRE-CANCER ATLAS DATA PORTAL. MAINTAIN ALL USER LOGINS AND DEVELOP NEW DATA PORTAL AND CBIOPORTAL FEATURES AS THEY BECOME RELEVANT FOR THE PROJECT. PROVIDE USER SUPPORT, DOCUMENTATION, AND OUTREACH FOR THE ENTIRE BRCA PRE CANCER ATLAS. EMORY UNIVERSITY 1390 OXFORD ROAD NE ATLANTA GA 30322 580566256 501(C)(3) 125000 0 MULTI-CONSORTIA COORDINATING CENTER (MC2 CETNER) FOR CANCER BIOLOGY: DEVELOP AND APPL QUALITY CONTROL WORKFLOWS TO ENSURE AI/ML-READINESS OF DIGITAL PATHOLOGY ACROSS MULTI-OMIC DATASETS, WITH CONTRIBUTIONS TO TOOL DEVELOPMENT, METRIC DEFINITION, EXPERIMENTAL DESIGN, AND COLLABORATIVE STUDY OVERSIGHT. INSTITUTE FOR SYSTEMS BIOLOGY 401 TERRY AVE N SEATTLE WA 98109 912003593 501(C)(3) 114897 0 EXCEPTIONAL LONGEVITY: PROVIDE SCIENTIFIC OVERSIGHT OF A WORKING GROUP CONDUCTING CROSS-PROJECT ANALYSES USING SYSTEMS BIOLOGY APPROACHES TO STUDY AGING, ALZHEIMERS DISEASE, AND THEIR INTERACTIONS. DUKE UNIVERSITY 2200 W MAIN ST STE 710 DURHAM NC 27705 560532129 501(C)(3) 103680 0 PHASE 1 AND 2: RECOVER MOBILE HEALTH PLATFORM/MOBILE HEALTH REPOSITORIES WORKING GROUP: DEVELOP PROCESS FOR MHP TO COLLECT PASC RELATED MOBILE HEALTH DATA FROM PARTICIPANTS AND SHARE THIS DATA WITH MHDR TO CLEAN CURATE, CONDUCT QA/QC, STORE AND PROVIDE ACCESS TO RESEARCHERS. CUSTOMIZATION OF THE MOBILE HEALTH PLATFORM, IMPLEMENTATION OF MOBILE DATA COLLECTION AMONG THE VARIOUS STUDIES, AS WELL AS, THE STORING, CURATION, LINKAGE, AND ANALYSES OF THE MOBILE HEALTH DATA. TUFTS MEDICAL CENTER 800 WASHINGTON ST BOSTON MA 02111 043400617 501(C)(3) 80688 0 EXCEPTIONAL LONGEVITY: SUPPORT DATA HARMONIZATION AND ANALYSIS FOR LONGEVITY RESEARCH, INCLUDING COLLABORATION ON A SYNTHETIC DATA CHALLENGE, WITH RESPONSIBILITIES FOR PROJECT OVERSIGHT, DATA PREPARATION, EVALUATION, AND REPORTING. UNIVERSITY OF CALIFORNIA LOS ANGELES 405 HILGARD AVE LOS ANGELES CA 90095 943067788 501(C)(3) 78426 0 ITCR, LEAD EVALUATION AND TESTING OF NEW SYNAPSE FEATURES AND THEIR INCORPORATION INTO MULTIPLE CHALLENGES, INCLUDING A LEAD STUDY OF PROSTATE CANCER ACTIVE SURVEILLANCE. PROVIDE STRATEGIC ADVICE, FEATURE-TESTING AND DEVELOPMENT, USAGE-SCENARIOS AND INTENSIVE TESTING. YALE UNIVERSITY 9 HILLHOUSE AVE NEW HAVEN CT 06511 060646973 501(C)(3) 70420 0 MULTI-CONSORTIA COORDINATING CENTER (MC2 CENTER) FOR CANCER BIOLOGY: BUILDING INTERDISCIPLINARY SCIENTIFIC COMMUNITIES, COORDINATING IMPACTFUL RESOURCE SHARING, AND ADVANCING CANCER RESEARCH. TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 445 N FIFTH ST PHOENIX AZ 85004 753065445 501(C)(3) 68791 0 EXCEPTIONAL LONGEVITY DATA MANAGEMENT AND COORDINATING CENTER, DEVELOP ANALYTICAL METHODS FOR ACCOMMODATING AND EXPLORING HETEROGENEITY IN LARGE AGGREGATED DATABASES. THEY WILL ALSO APPLY THESE METHODS WITH THE OTHER INVESTIGATORS AS WELL AS RESEARCHERS ASSOCIATED WITH THE CONSORTIA THAT GENERATED THE AGGREGATED DATA. STANFORD UNIVERSITY 450 JANE STANFORD WAY STANFORD CA 94305 941156365 501(C)(3) 50000 0 MULTI-CONSORTIA COORDINATING CENTER (MC2 CENTER) FOR CANCER BIOLOGY: WORK WITH SAGE TO DEVELOP A PILOT WEB APPLICATION FOR EXPLORING SPATIAL TRANSCRIPTOMIC DATA IN CANCER RESEARCH. UNIVERSITY OF WASHINGTON 1410 NE CAMPUS PKWY SEATTLE WA 98195 916001537 501(C)(3) 36580 0 AMP AD KNOWLEDGE PORTAL: BUILD INTEROPERABILITY BETWEEN TWO MAJOR ALZHEIMER'S RESEARCH PLATFORMS BY CREATING BIDIRECTIONAL METADATA FLOWS, ENABLING RESEARCHERS TO DISCOVER AND ACCESS MULTI-OMIC, MICROBIOME, IMAGING, AND CLINICAL DATASETS ACROSS SYSTEMS THROUGH INTEGRATED TOOLS, AUTOMATED REQUESTS, AND ENHANCED COHORT SELECTION CAPABILITIES. UNIVERSITY OF COLORADO DENVER 2199 S UNIVERSITY BLVD DENVER CO 80208 840644739 501(C)(3) 13649 0 PROVIDE SUPPORT FOR GOVERNANCE ISSUES AND REGULATORY COORDINATION WITH NIH, PROVIDING TECHNICAL MANAGEMENT SUPPORT FOR PROJECT TEAMS, TRAINING AND COORDINATION FOR SITES TO PARTICIPATE IN ANALYTICAL ACTIVITIES, AND SUPPORT FOR PUBLIC RELATIONS AND DISSEMINATION OF RESEARCH OUTCOMES FOR THE COVID 19 COHORT COLLABORATIVE FOR DISEASE MODELING PROJECT. THE BROAD INSTITUTE 415 MAIN STREET CAMBRIDGE MA 02142 263428781 501(C)(3) 6757 0 AMP AD KNOWLEDGE PORTAL: EXTEND THE ALZHEIMER'S DISEASE DATA COORDINATION CENTER BY INTEGRATING SAGE-HOSTED DATA WITH THE TERRA PLATFORM, ENABLING SECURE ACCOUNT LINKING, DATA ACCESS, AND SYNTHETIC COHORT HANDOFFS, WITH ONGOING TECHNICAL UPDATES AND CROSS-TEAM COORDINATION OVER THE AWARD PERIOD. 15 1 SCHEDULE I, PART I, LINE 2 IN SOME CASES, GRANTS RECEIVED BY SAGE BIONETWORKS ARE PASSED ON TO SUB-RECIPIENTS THROUGH A SUB-AWARD AGREEMENT. THE GRANT MANAGER IS RESPONSIBLE FOR INITIATING THE SUB-AWARD AGREEMENT AFTER OBTAINING BUDGET APPROVAL FROM THE PI AND COO. WHILE ISSUING A SUB-AWARD, THE GRANT MANAGER IS RESPONSIBLE FOR: OBTAINING VERIFICATION OF THE SUB-AWARDEE'S F&A RATES AND SINGLE AUDIT REPORT, REVIEWING THE PRIME AWARD TERMS AND CONDITIONS TO DETERMINE WHETHER THEY ARE APPLICABLE TO THE SUB-AWARD, AND DETERMINING WHETHER THE SUB-AWARDEE MEETS ALL OF THE OTHER ADMINISTRATIVE AND REGULATORY REQUIREMENTS OF THE PRIME AWARD. ONCE THE SUB-AWARD HAS BEEN ISSUED, THE GRANTS MANAGER IS RESPONSIBLE FOR FORWARDING THE FULLY EXECUTED SUB-AWARD DOCUMENTS TO THE ACCOUNTING MANAGER TO ENSURE PROPER BILLING. PAYMENTS ARE MADE ONLY AFTER SUBAWARD AGREEMENT HAS BEEN EXECUTED BY BOTH PARTIES AND INVOICES HAVE BEEN APPROVED BY THE PI. EACH YEAR OF THE ACTIVE SUBAWARD AGREEMENT, THE GRANTS MANAGER PERFORMS CONTINUING RISK ASSESSMENTS TO ENSURE THAT THE SUB-AWARDEE CONTINUES TO BE ELIGIBLE AND DOCUMENTS THAT ASSESSMENT. X X 0 0 0 0 0 0 0 0 0 LUCA FOSCHINI PRESIDENT & CEO 365453 0 0 0 0 0 22500 0 35921 0 423874 0 0 0 KIMBERLY BAGGETT COO, CFO AND SECRETARY 298476 0 0 0 17521 0 21199 0 32392 0 369588 0 0 0 BRUCE HOFF TECHNICAL DIRECTOR IT 196217 0 0 0 0 0 13984 0 31192 0 241393 0 0 0 CHRISTINE FABRE SUVER CHIEF PRIVACY & COMPLIANCE OFFICER 193002 0 0 0 0 0 13946 0 29865 0 236813 0 0 0 SUSHEEL VARMA CHIEF SCIENTIFIC & DATA OFFICER 203207 0 14864 0 0 0 8657 0 5162 0 231890 0 0 0 KEVIN BOSKE ASSOCIATE TECHNICAL DIRECTOR 181458 0 0 0 0 0 12859 0 29398 0 223715 0 0 0 JAY HODGSON TECHNICAL DIRECTOR WEB ENGINEERING 189428 0 0 0 0 0 13467 0 19693 0 222588 0 0 0 SOLVEIG SIEBERTS DIRECTOR DIGITAL HEALTH 184983 0 0 0 0 0 13004 0 10610 0 208597 0 0 0 MARCO MARASCA PRINCIPAL SOFTWARE ENGINEER 180493 0 0 0 0 0 12557 0 0 0 193050 0 0 0 ANNA GREENWOOD DIRECTOR ADTR (THRU 10/24) 159015 0 0 0 0 0 11110 0 7832 0 177957 0 0 0 PART I, LINE 6 THE VOLUNTEER COUNT IS ENTIRELY MADE UP OF THE INDEPENDENT MEMBERS OF OUR BOARD OF DIRECTORS- HOURS ARE FOR THEIR SERVICE IN THAT CAPACITY. WE ESTIMATE THIS IS APPROXIMATELY 140 HOURS PER YEAR (APPROXIMATELY 20 HOURS/YR PER BOARD MEMBER). FORM 990, PART VI, SECTION B, LINE 11B THE 990 DRAFT IS PREPARED BY CLARK NUBER AND THEN REVIEWED BY THE CEO, COO AND DIRECTOR OF FINANCE VIA A WALK THROUGH PRIOR TO FILING AND DISTRIBUTED TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A FCOI THAT COMPILES WITH NATIONAL INSTITUTES OF HEALTH SPECIFIC REQUIREMENTS PROMOTING OBJECTIVITY IN RESEARCH. ON AN ANNUAL BASIS, SAGE BIONETWORKS OFFICERS, BOARD OF DIRECTORS, KEY EMPLOYEES AND ALL EMPLOYEES SERVING AS AN INVESTIGATOR ON FEDERAL AWARDS MUST REVIEW AND SUBMIT AN AD HOC DISCLOSURE OF SIGNIFICANT FINANCIAL INTEREST. THEY ARE ALSO REQUIRED TO DISCLOSE ANY CONFLICT OF INTEREST WITHIN 30 DAYS OF DISCOVERING OR ACQUIRING SAID INTEREST. FORMS ARE REVIEWED ANNUALLY BY THE COO AND PERIODICALLY REVIEWED BY OUTSIDE COUNSEL. FORM 990, PART VI, SECTION B, LINE 15A EXECUTIVE COMPENSATION IS SET BY THE BOARD OF DIRECTORS COMPENSATION COMMITTEE AND REVIEWED ANNUALLY. COMPENSATION FOR OTHER OFFICERS AND KEY EMPLOYEES IS REVIEWED EACH JANUARY BY THE DIRECTOR OF FINANCE, HR AND EXECUTIVE LEADERSHIP TEAM AND BENCHMARKED TO CULPEPER COMPENSATION SURVEYS TO SIMILAR SIZED ORGANIZATIONS AND ROLES. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS ARE MADE AVAILABLE ON THE COMPANY WEBSITE.